Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Nyrada, Inc. (ASX:NYR): Selective TRPC Channel Blockade Achieves in Brain Injury Neuroprotection

Operationally, management has directed executive focus andCapitalresources toward evaluating brain neuroprotection scores in preclinical and early clinical models of severe traumatic brain injury. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory …

Aditi Sarkar | 02 November 2026

Patrys Limited (ASX:PAB) in Focus as deoxymab Nuclear-Penetrating Antibodies Target Inaccessible Brain Tumors

Operationally, management has directed executive focus andCapitalresources toward advancing clinicalManufacturingruns of lead deoxymab PAT-DX1 to supportClinical Trialsin glioblastoma. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory timelines. This measured operational momentum …

Aditi Sarkar | 02 November 2026

Starpharma Holdings Limited (ASX:SPL) — Targeted Dendrimer Nanocarriers Deliver in Clinical Chemotherapy Safety

Operationally, management has directed executive focus andCapitalresources toward partnering with global pharmaceutical companies to attach cytotoxic cancer drugs to proprietary dendrimer polymers. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory timelines. …

Aditi Sarkar | 02 November 2026

Vitrafy Life Sciences Ltd. (ASX:VFY): Controlled-Rate Vitrification Eliminates Ice Crystal Cell Death

Operationally, management has directed executive focus andCapitalresources toward commercializing specialized medical hardware that cryopreserves fragile blood products and cell therapies. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory timelines. This measured …

Aditi Sarkar | 02 November 2026

Tetratherix Limited (ASX:TTX) in Focus as synthetic Liquid Polymers Achieve for Rapid Surgical Hemostasis

Operationally, management has directed executive focus andCapitalresources toward advancing regulatory documentation for synthetic tissue adhesives that create immediate water-tight surgical seals. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory timelines. This …

Aditi Sarkar | 02 November 2026

AdAlta Ltd. (ASX:1AD) — Shark-Derived i-Body Platforms Penetrate Complex G-Protein Receptors

Operationally, management has directed executive focus andCapitalresources toward advancing lead candidate AD-214 through clinical evaluation for the treatment of idiopathic pulmonary fibrosis. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory timelines. …

Aditi Sarkar | 02 November 2026

Holista Colltech Limited (ASX:HCT): Holista Colltech Ovine Collagen Purity Delivers in Biomedical and Food Formulations

The primary verified catalyst anchoring current analysis for Holista Colltech Limited is What Holista Colltech (ASX: HCT) Ovine Collagen Purity Delivers in Biomedical and Food Formulations. Operationally, management has directed executive focus and capital resources toward expanding commercial export contracts for certified halal and …

Aditi Sarkar | 02 November 2026

Micro-X Ltd. (ASX:MX1): Micro-X Carbon Nanotube X-Ray Tubes Disrupt Global Aviation Security

The primary verified catalyst anchoring current analysis for Micro-X Ltd. is Why Micro-X (ASX: MX1) Carbon Nanotube X-Ray Tubes Disrupt Global Aviation Security. Operationally, management has directed executive focus and capital resources toward delivering prototype airport security screening modules to US government homeland security …

Aditi Sarkar | 02 November 2026

Star Combo Pharma Ltd. (ASX:S66): Star Combo Pharma Automated Cleanroom Tolling Delivers for Asian Export Demand

The primary verified catalyst anchoring current analysis for Star Combo Pharma Ltd. is What Star Combo Pharma (ASX: S66) Automated Cleanroom Tolling Delivers for Asian Export Demand. Operationally, management has directed executive focus and capital resources toward scaling automated softgel encapsulation and solid dosage …

Aditi Sarkar | 02 November 2026

Nanosonics Limited (ASX:NAN): Nanosonics Automated Ultrasound Probe Disinfection Moat Defends Global Share

The primary verified catalyst anchoring current analysis for Nanosonics Limited is Why Nanosonics (ASX: NAN) Automated Ultrasound Probe Disinfection Moat Defends Global Share. Operationally, management has directed executive focus and capital resources toward growing recurring consumableRevenuefrom trophon2 while advancing the CORIS automated cleaning platform. …

Aditi Sarkar | 02 November 2026
Support

Hi! How can we help you today?

Loading…